(Press-News.org) COLUMBUS, Ohio -- Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as possibly safer, more effective and less costly alternatives to the monoclonal-antibody-based drugs and small-molecule inhibitors now used to treat many malignancies.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have identified two regions on the HER1/EGFR receptor, a protein important for cancer-cell growth and metastasis and for poor patient survival, as targets for peptide agents.
The receptor molecule protrudes from the surface of cancer cells in abnormally high numbers. It is activated by growth factors in the blood and released by other cells in the tumor, stimulating tumor growth.
"Our findings could lead to novel peptide vaccines and mimetic inhibitors that target HER1 in tumors of the breast, lung, colon and head and neck, and that overcome many of the significant shortcomings of antibody-based drugs such as cetuximab," says principal investigator Pravin Kaumaya, PhD, director of the division of vaccine development at the OSUCCC - James.
"Such peptide agents might enable the development of combination immunotherapies using either HER2 vaccines or VEGF therapy that avoid the mechanisms of resistance or secondary treatment failures sometimes experienced with antibody treatment," says Kaumaya, who is also professor of obstetrics and gynecology, of molecular and cellular biochemistry, and of microbiology at Ohio State.
The study is published in the Journal of Immunology.
HER1 is a member of the epithelial growth factor (EGF) family of cell-surface receptors, which includes the HER2 receptor. These receptors play a central role in the development of a variety of human cancers, including certain breast cancers, lung cancer, colorectal and head and neck cancers.
Kaumaya and his colleagues evaluated three sequences of peptides to determine which were the most specific and immunogenic (i.e., raised the strongest immune response in test animals), and therefore were best suited for use as vaccines or therapeutics. The three sequences, or epitopes, were based on the site of contact between HER1 and the growth factor that normally binds with it, epithelial growth factor (EGF).
Key technical findings included:
Two of the sequences (382-410 and 418-435) were identified as best for use as cancer therapy or a cancer vaccine;
The 382-410 epitope overlaps the binding site of cetuximab, an antibody agent that inhibits HER1 binding; however, the 418-435 epitope significantly inhibited tumor growth in transplantable breast and lung cancer models;
The vaccine constructs were highly immunogenic and established immunological memory in a rabbit model.
"Overall," Kaumaya says, "our results show that the 418-435 epitope has great potential for use as a vaccine or treatment option for HER1-expressing cancers."
###
Funding from the NIH/National Cancer Institute (grant CA084356) supported this research.
Other Ohio State researchers involved in this study were Kevin Chu Foy, Ruthie M. Wygle, Megan J. Miller, Jay P. Overholser and Tanios Bekaii-Saab.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 228-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S.News & World Report.
Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents
2013-07-24
ELSE PRESS RELEASES FROM THIS DATE:
University of Alberta scientists get dirty at the Robson Glacier
2013-07-24
Glacier retreat areas provide an excellent window into the evolution of microbial communities, an ideal opportunity for scientists to study how quickly soil biological functions become established and how ecosystems begin to form. Soils are not static in the landscape, but instead evolve with time under the influence of multiple environmental factors – understanding how these factors interact can lead to advancements in the science and management of soils.
Aria Hahn and Dr. Sylvie Quideau, researchers at the University of Alberta, conducted their research in Mount Robson ...
A quick test for the Black Death
2013-07-24
This news release is available in German. Diagnosing the presence of Yersinia pestis, the cause of plague, may soon be easier than ever before. Scientists working with Peter Seeberger, Director at the Max Planck Institute of Colloids and Interfaces (MPIKG) in Potsdam and Professor at the Freie Universität Berlin, have come up with a simple, inexpensive and reliable method of detecting the bacterium. The research team, specialising in glycochemistry and glycobiology, first identified and synthesised an oligosaccharide structure on bacterial surface before combining ...
University of Minnesota research reveals luxury products' role in relationships
2013-07-24
Purchasing designer handbags and shoes is a means for women to express their style, boost self-esteem, or even signal status. New University of Minnesota research suggests some women also seek these luxury items to prevent other women from stealing their man.
Through a series of five experiments featuring 649 women of varying ages and relationship statuses, Carlson School of Management Associate Professor Vladas Griskevicius and PhD student Yajin Wang discovered how women's luxury products often function as a signaling system directed at other women who pose a threat ...
Medicare spending rates based on regional cost variations unlikely to improve health care
2013-07-24
WASHINGTON -- A "geographic value index" that would tie Medicare payment rates to the health benefits and costs of health services in particular regions of the country should not be adopted by Congress, says a new congressionally mandated report from the Institute of Medicine. The committee that wrote the report concluded that decisions about health care generally are made at the level of the physician or organization, such as a hospital, not at the regional level. Because individual physician performance varies, sometimes even within a single practice group, an index ...
Carnegie Mellon biophysicist obtains first experimental evidence of pressure inside the herpes virus
2013-07-24
PITTSBURGH - Herpes viruses are like tiny powder kegs waiting to explode. For more than 20 years scientists suspected that herpes viruses were packaged so full of genetic material that they built up an internal pressure so strong it could shoot viral DNA into a host cell during infection. No one had been able to prove that theory until now.
Carnegie Mellon University biophysicist Alex Evilevitch together with his graduate student David Bauer and University of Pittsburgh collaborators Fred Homa and Jamie Huffman have measured, for the first time, the pressure inside human ...
High rate of early delirium after surgery in older adults
2013-07-24
San Francisco, CA. (July 24, 2013) – Close to half of older adults undergoing surgery with general anesthesia are found to have delirium in the postanesthesia care unit (PACU), according to a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Delirium occurring early after surgery is linked to decreased cognitive (mental) function and an increased rate of nursing home admission, according to the study by Dr Karin J. Neufeld of Johns Hopkins University and colleagues. They write, "Recognizing ...
Patient warming systems may affect ventilation in OR, study suggests
2013-07-24
San Francisco, CA. (July 24, 2013) – Forced-air systems used to keep patients warm during surgery may affect the performance of operating room (OR) ventilation systems—potentially increasing exposure to airborne contaminants, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
By comparison, conductive warming systems don't disrupt ventilation airflows over the surgical site, according to the report by Dr Kumar G. Belani of University of Minnesota and colleagues. But an accompanying ...
Coping with the global scarcity of clean water
2013-07-24
Efforts to cope with a global water crisis that already has left almost 800 million people without access to drinkable water -- and could engulf many more in the years ahead -- are the topic of the cover story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Alex Scott, C&EN's senior editor for Europe, points out that most companies involved in water treatment technologies focus on providing services in wealthy industrialized nations. But today's most critical ...
Univ. of MD finds that marijuana use in adolescence may cause permanent brain abnormalities
2013-07-24
Regular marijuana use in adolescence, but not adulthood, may permanently impair brain function and cognition, and may increase the risk of developing serious psychiatric disorders such as schizophrenia, according to a recent study from the University of Maryland School of Medicine. Researchers hope that the study, published in Neuropsychopharmacology — a publication of the journal Nature – will help to shed light on the potential long-term effects of marijuana use, particularly as lawmakers in Maryland and elsewhere contemplate legalizing the drug.
"Over the past 20 ...
URMC study clarifies surgical options for kidney cancer
2013-07-24
Surgery is often the first step in treating kidney cancer, and new data from the University of Rochester Medical Center, which contradicts earlier research, questions whether removal of only the tumor (partial nephrectomy) is better than removing the entire kidney (radical nephrectomy).
The decided trend for the past decade has been toward a partial resection in the case of smaller cancers. It was based on several earlier studies suggesting that it's better to save as much kidney tissue as possible, and thus preserve kidney function and reduce the likelihood of kidney ...